Author:
Huibers Anne,DePalo Danielle K.,Perez Matthew C.,Zager Jonathan S.,Olofsson Bagge Roger
Abstract
AbstractPatients with cutaneous melanoma can develop in-transit metastases (ITM), most often localized to limbs. For patients with uveal melanoma that develop metastatic disease, the overall majority develop isolated liver metastases. For these types of metastases, regional cancer therapies have evolved as effective treatments. Isolated limb perfusion (ILP), isolated limb infusion (ILI), isolated hepatic perfusion (IHP) and percutaneous hepatic perfusion (PHP) achieve a high local concentration of chemotherapy with minimal systemic exposure. This review discusses the mechanism and available literature on locoregional treatment modalities in the era of modern immunotherapy.
Funder
Merck
Novartis Pharmaceuticals Corporation
Philogen
Castle Biosciences
Pfizer
Sun Pharma
Istari
Amgen
Delcath Systems
Provectus
Bristol-Myers Squibb
Endomagnetics Ltd
SkyLineDx
Roche
Pierre-Fabre
BD/BARD
Merck Sharp & Dohme
Roche and Sanofi Genzyme
SATMEG Ventures AB
University of Gothenburg
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献